| YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs |
Globe Newswire |
10/20 |
06:55 |
| Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy |
Globe Newswire |
10/20 |
06:30 |
| Miata Intersects 43.0 m at 2.42 g/t Au, Including 4.0 m at 17.11 g/t Au at Jons Trend and Confirms Continuity with Big Berg at Sela Creek, Suriname |
Globe Newswire |
10/20 |
06:30 |
| Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study |
Globe Newswire |
10/20 |
06:18 |
| Dime Commercial Bancshares, Inc. Reports 53% Year-Over-Year Increase in EPS |
Globe Newswire |
10/20 |
06:15 |
| ES Bancshares, Inc. Announces Third Quarter 2026 Results; Tenth Consecutive Quarter of Growth in Our Book Value Per Share |
Globe Newswire |
10/20 |
06:15 |
| Dime Commercial Bancshares, Inc. Enhances Staten Island Presence and Franchise Value Through Agreement to Acquire ES Bancshares, Inc. |
Globe Newswire |
10/20 |
06:15 |
| Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP) |
Globe Newswire |
10/20 |
06:00 |
| Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania |
Globe Newswire |
10/20 |
06:00 |
| WasabiCard Expands Its Stablecoin Payments Ecosystem and Joins Open USD as an Official Ecosystem Partner |
Globe Newswire |
10/20 |
06:00 |
| Crypto News: Pepeto Announces Its 160% APY Staking Stays Live While the Solana Price Prediction Targets $2,744 |
Globe Newswire |
10/20 |
05:51 |
| Sabre Cybersecurity Warns Ohio Businesses That Ransomware Attacks Strike When Nobody Is Watching |
Globe Newswire |
10/20 |
05:51 |
| Sword Appoints Dr. Adam Wolfberg as Chief Medical Officer |
Globe Newswire |
10/20 |
05:45 |
| Heineken® teams up with Amazon to launch "Pubscription"... The world’s first streaming service for nights out |
Globe Newswire |
10/20 |
05:21 |
| Sutherland and FlowX.AI Partner to Deliver Enterprise-Grade AI Solutions for Complex, Regulated Industries |
Globe Newswire |
10/20 |
05:12 |
| Future Travel Starts Now: 2026 JETOUR Global Technology Experience Day Kicks Off |
Globe Newswire |
10/20 |
05:02 |
| Fortuna intersects 0.96 g/t gold over 350 meters at the Lindero Mine, Argentina |
Globe Newswire |
10/20 |
05:00 |
| PONY AI Inc. to Report Third Quarter 2026 Financial Results on November 18, 2026 |
Globe Newswire |
10/20 |
05:00 |
| Hesai Group to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026 |
Globe Newswire |
10/20 |
04:30 |
| Sixthfin Launches T&E Controls Software 2026 - Travel and Expense Controls Solution for Finance, Audit and Internal Control Departments Analyses 100% of Expense Claims After Approval |
Globe Newswire |
10/20 |
04:10 |
| VR Receives NOI Permit with Expanded Drill Site Coverage for its New Boston Moly-Copper-Tungsten- Silver Porphyry Project in Nevada |
Globe Newswire |
10/20 |
04:00 |
| Water shortages will threaten growth within five years, say over half of European industrial leaders |
Globe Newswire |
10/20 |
03:31 |
| Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors |
Globe Newswire |
10/20 |
03:30 |
| Gesynta Pharma completes enrollment in Phase 2 NOVA trial evaluating vipoglanstat in endometriosis |
Globe Newswire |
10/20 |
03:30 |
| AltruBio Presents Phase 2a Data of ALTB-268 in Advanced Therapy-Refractory Ulcerative Colitis at UEG Week 2026 |
Globe Newswire |
10/20 |
03:15 |
